SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-20-104499
Filing Date
2020-09-14
Accepted
2020-09-11 17:40:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 POS AM tm2030533d3_posam.htm POS AM 587406
2 EXHIBIT 23.1 tm2030533d3_ex23-1.htm EX-23.1 3467
  Complete submission text file 0001104659-20-104499.txt   592043
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: POS AM | Act: 33 | File No.: 333-234219 | Film No.: 201171845
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences